Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             205 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Abnormal Bone Microindentation Test in a Diaphiseal Femur Fractur After Long-Term Bisphosponates Güerri, Roberto
2010
46 S1 p. S22-
1 p.
artikel
2 Absence of bone remodeling compartment canopies correlates with deficient bone formation in post-menopausal women Andersen, Thomas
2010
46 S1 p. S67-S68
2 p.
artikel
3 Adenosine A2b Receptors Induce Osteoblastogenesis Whereas A1 Receptors Induce Adipogenesis Gharibi, Borzo
2010
46 S1 p. S48-S49
2 p.
artikel
4 Analysis of bone mineral density and body composition at different parts and ages in chinese men Li, Yukun
2010
46 S1 p. S73-
1 p.
artikel
5 Analysis of bone mineral density and body composition at different parts and ages in Chinese women Li, Baoxin
2010
46 S1 p. S73-S74
2 p.
artikel
6 Analysis of osteoblast transcriptome in osteoporosis Trošt, Zoran
2010
46 S1 p. S54-
1 p.
artikel
7 Anemia and the risk of non-vertebral fractures Jørgensen, Lone
2010
46 S1 p. S72-
1 p.
artikel
8 Anti-tumor effects of bisphosphonates in man - myth or reality? Coleman, Robert
2010
46 S1 p. S18-
1 p.
artikel
9 A Soluble BMP Antagonist Polypeptide Increases Bone Mass and Improves Bone Strength Solban, Nicolas
2010
46 S1 p. S32-S33
2 p.
artikel
10 Autocrine Fibroblast Growth Factor 18 mediates dexamethasone-induced osteogenic differentiation of murine mesenchymal stem cells Hamidouche, Zahia
2010
46 S1 p. S54-
1 p.
artikel
11 Autocrine/paracrine action of Vitamin D on FGF23 expression in cultured rat osteoblasts Tang, Wen-jing
2010
46 S1 p. S71-
1 p.
artikel
12 Autophagy and Paget's disease of bone Hocking, Lynne
2010
46 S1 p. S63-
1 p.
artikel
13 A win for bisphosphonates? Comparison between local bisphosphonate release and hydroxyapatite coating for screw fixation in rats Agholme, Fredrik
2010
46 S1 p. S67-
1 p.
artikel
14 Bazedoxifene reduces non-vertebral fractures in patients at high probability of fracture McCloskey, Eugene
2010
46 S1 p. S26-
1 p.
artikel
15 Bisphosphonate-associated osteonecrosis of the jaw bones: diagnosis and surgical management of a serious complication Umbreit, Sandra
2010
46 S1 p. S40-
1 p.
artikel
16 BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO Mabilleau, Guillaume
2010
46 S1 p. S63-S64
2 p.
artikel
17 BONE DENSITY DECREASED IN FEMALE CHILD Bazarra-Fernandez, Antonio
2010
46 S1 p. S19-
1 p.
artikel
18 BONE MINERAL DENSITY AND LIVER DISORDERS Bazarra-Fernandez, Antonio
2010
46 S1 p. S68-S69
2 p.
artikel
19 BONE MINERAL ULTRASTRUCTURE IN WHITE ADULT RATS UNDER THE IMPACT OF THE DIFFERENT MODES OF CHRONIC HYPERTHERMIA IN COMBINATION WITH THE PHYSICAL ACTIVITY AND POSSIBLE CORRECTION WITH INOSINE Smolenchuk, Svetlana
2010
46 S1 p. S26-
1 p.
artikel
20 Bone Morphogenetic Protein-2 - Adsorption and Release Behaviour on Clinically Relevant Materials Hänseler, Patrick
2010
46 S1 p. S49-
1 p.
artikel
21 Bone ridge patterning during musculoskeletal assembly is mediated through SCX regulation of Bmp4 at the tendon-skeleton junction Zelzer, Elazar
2010
46 S1 p. S59-
1 p.
artikel
22 Bovine Lactoferrin improves bone status of ovariectomized mice via immune function modulation Blais, Anne
2010
46 S1 p. S69-
1 p.
artikel
23 Calcitonin and alendronate activate Ca2+-permeable cation conductances with distinct transient receptor potential properties in murine osteoclasts Albert, Anthony
2010
46 S1 p. S60-
1 p.
artikel
24 Calcium supplement effects on vascular events - is it worth the risk? Reid, Ian
2010
46 S1 p. S15-S16
2 p.
artikel
25 β-catenin is a key mediator in the development of intervertebral disc tissue degeneration Chen, Di
2010
46 S1 p. S12-S13
2 p.
artikel
26 Cathepsin K - A Novel Molecular Target for Treatment of Osteoporosis: Discovery of Odanacatib Rodan, Sevgi
2010
46 S1 p. S14-S15
2 p.
artikel
27 Cell Cycle-Arrested Osteoclast Precursors Takahashi, Naoyuki
2010
46 S1 p. S10-
1 p.
artikel
28 Change of properties of mononuclear leukocytes at patients with an osteogenesis imperfecta after operative treatment with using nanosized hydroxylapatite coatings Saprina, Tatjana
2010
46 S1 p. S69-S70
2 p.
artikel
29 CHANGES OF BLOOD VESSELS OF VENTRAL PART OF SPINE IN THE CONDITIONS OF AT PROTRACTED RUN IN EXPERIMENT Koveshnikov, Vladimir
2010
46 S1 p. S25-S26
2 p.
artikel
30 Chemokine and lipid mediator-mediated control of osteoclast migration visualized by in vivo bone imaging: A novel point of regulation for bone homeostasis Ishii, Masaru
2010
46 S1 p. S10-S11
2 p.
artikel
31 Chondrogenesis and Pattering Mundlos, Stefan
2010
46 S1 p. S9-
1 p.
artikel
32 Chondrogenic potential human adipose-derived stem cells after in vivo transplantation with a cellulose hydrogel Merceron, Christophe
2010
46 S1 p. S77-S78
2 p.
artikel
33 COMBINED USE OF CALCITONIN AND ALENDRONATE IN HIV-INFECTED WITH BONE MASS LOSS Bazarra-Fernandez, Antonio
2010
46 S1 p. S20-
1 p.
artikel
34 COMPARE - Results of a randomised study to assess the renal safety and efficacy of ibandronate and zoledronate in multiple myeloma patients Bergner, Raoul
2010
46 S1 p. S34-S35
2 p.
artikel
35 Complementary and Alternative Therapies : Rheumatoid Arthritis Juturu, Vijaya
2010
46 S1 p. S24-
1 p.
artikel
36 Composite calcium phosphate chitosan coating on the basis of nanostructured hydroxyapatite coating for medical applications Zelichenco, Elena
2010
46 S1 p. S50-
1 p.
artikel
37 Conditioned medium collected from mature osteoclasts augments bone formation, while activating cartilage degradation Henriksen, Kim
2010
46 S1 p. S62-
1 p.
artikel
38 Denosumab and Alendronate Have Different Effects at the Ultradistal Radius in Postmenopausal Women With Low Bone Mass Libanati, Cesar
2010
46 S1 p. S28-S29
2 p.
artikel
39 Denosumab to Prevent Disease and Treatment-Related Skeletal Complications in Men with Prostate Cancer: Emerging Evidence Smith, Matthew
2010
46 S1 p. S17-S18
2 p.
artikel
40 Designed mutants of human farnesyl pyrophosphate synthase (FPPS) help to characterise the interactions of nitrogen-containing bisphosphonates with Tyrosine 204 and Phenylalanine 239 side-chain residues Tsoumpra, Maria
2010
46 S1 p. S23-
1 p.
artikel
41 Determination of the relative bone mineral-binding affinities of bisphosphonates by using hydroxyapatite-column chromatography combined with mass spectrometric analysis Duan, Xuchen
2010
46 S1 p. S23-
1 p.
artikel
42 Developing injectable bone substitutes: In vitro findings and preclinical studies Agis, Hermann
2010
46 S1 p. S71-S72
2 p.
artikel
43 Different concentrations of sodium selenite affect IGF-I and IGF-IR expression in mouse osteoblasts and regulate cells proliferation in vitro Ren, Gaixian
2010
46 S1 p. S49-
1 p.
artikel
44 Differential effects of angiotensin II-receptor blockade on vascular and skeletal manifestations of Marfan syndrome Nistala, Harikiran
2010
46 S1 p. S27-
1 p.
artikel
45 Do dose and acidic environment facilitate the manifestation of osteonecrosis of the jaw by increasing local bisphosphonate toxicity? Otto, Sven
2010
46 S1 p. S41-
1 p.
artikel
46 Doxorubicin Therapy Causes Additional Bone Loss in Preclinical Osteolytic Breast Cancer Model Biswas, Swati
2010
46 S1 p. S35-
1 p.
artikel
47 Editorial Board 2010
46 S1 p. i-ii
nvt p.
artikel
48 Effect of Denosumab on the Incidence of Hip and New Vertebral Fractures in Postmenopausal Women With High Fracture Risk: A Subanalysis of the FREEDOM Study Lippuner, Kurt
2010
46 S1 p. S27-S28
2 p.
artikel
49 Effect of ibandronate infusion duration (15 min versus 60 min) on renal function in breast cancer patients with bone metastases Frimat, Luc
2010
46 S1 p. S36-
1 p.
artikel
50 Effect of ibandronate on tumor cells in the bone marrow and in blood in patients with primary breast cancer. A pilot study Kasimir-Bauer, Sabine
2010
46 S1 p. S38-
1 p.
artikel
51 EFFECT OF ZOLENDRONIC ACID IN TREATMENT OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS Povoroznyuk, Vladyslav
2010
46 S1 p. S30-
1 p.
artikel
52 Effects of a sulphated exopolysaccharide produced by Alteromonas infernus on bone cells Velasco, Carmen Ruiz
2010
46 S1 p. S80-
1 p.
artikel
53 EFFECTS OF BIOGENIC HYDROXYAPATITE IMPLANTS ON GROWTH AND FORMATION OF MANDIBLE IN RATS Luzin, Vladyslav
2010
46 S1 p. S74-
1 p.
artikel
54 Effects of cyclic diarylheptanoids on osteoblastic differentiation and bone formation in vitro and in vivo Woo, Je Tae
2010
46 S1 p. S58-
1 p.
artikel
55 EFFECTS OF ELECTROMAGNETIC FIELD AND CHLOROBENZENES TREATMENT ON BONE AND CONNECTIVE TISSUE IN RATS Valkusz, Zsuzsanna
2010
46 S1 p. S82-
1 p.
artikel
56 Effects of oxygen tension on the chondrogenic potential of differentially cultured human adipose-derived stem cells Merceron, Christophe
2010
46 S1 p. S78-
1 p.
artikel
57 Effects of oxygen tension on the hypertrophic terminal differentiation of chondrogenic cells Sophie, Portron
2010
46 S1 p. S81-S82
2 p.
artikel
58 Efficacy of loading-dose ibandronate for rapid pain relief in patients with advanced breast carcinoma and bone metastases Sittig, Hans-Bernd
2010
46 S1 p. S39-
1 p.
artikel
59 Equilibrium binding affinity constants of the soy isoflavone genistein to all human full-length estrogen receptors present in human primary osteoblasts Bendik, Igor
2010
46 S1 p. S45-
1 p.
artikel
60 Esophageal ulceration in a patient with kyphoscoliosis and newly diagnosed osteoporosis Rainer, Peter
2010
46 S1 p. S31-
1 p.
artikel
61 17β-estradiol positively modulates GH signaling in human osteoblast-like cells Villa, Isabella
2010
46 S1 p. S57-S58
2 p.
artikel
62 Ewing's Sarcoma Cells Promote Osteoclast Formation Taylor, Richard
2010
46 S1 p. S65-
1 p.
artikel
63 Expression of a store-operated conductance and mRNA for canonical transient receptor potential and Orai in murine osteoclasts Lau, Brenda
2010
46 S1 p. S60-
1 p.
artikel
64 Expression of lyosophospholipase D/autotaxin by breast cancer cells controls bone metastasis formation by increasing osteoclast differentiation David, Marion
2010
46 S1 p. S41-
1 p.
artikel
65 Extracellular nucleotides regulate the expression and activity of ecto-nucleotidases by osteoblasts Orriss, Isabel
2010
46 S1 p. S55-
1 p.
artikel
66 Forkhead Box O (FoxO) Transcription Factors in the Actions of 1,25-Dihydroxyvitamin D3 on Osteoblasts Eelen, Guy
2010
46 S1 p. S48-
1 p.
artikel
67 Formation of bony structures by cultured long bone osteoblasts: potent inhibition by parathyroid hormone Taylor, Sarah
2010
46 S1 p. S56-S57
2 p.
artikel
68 Frequent Intermittent Low-dose Therapy Accentuates the Antitumour Activity of the Bisphosphonate Risedronate In Vivo Stresing, Verena
2010
46 S1 p. S43-
1 p.
artikel
69 Genetics of muscle Orwoll, Eric
2010
46 S1 p. S16-S17
2 p.
artikel
70 Genomewide Studies in Osteoporosis Brown, Matt
2010
46 S1 p. S12-
1 p.
artikel
71 Geometric Control of Tissue Growth Bidan, Cécile
2010
46 S1 p. S47-S48
2 p.
artikel
72 Glutamatergic signals in human arthritis: A link between mechanical, nociceptive and pathological processes Mason, Deborah
2010
46 S1 p. S76-
1 p.
artikel
73 GM-CSF released by osteoblasts in response to TNFalpha inhibits osteoclastogenesis in vitro Atanga, Elvis
2010
46 S1 p. S60-S61
2 p.
artikel
74 GnRH analogue treatment and decrease of bone mass density (BMD) in a patient with Osteogenesis Imperfecta (OI) and Central Precocious Puberty (CPP) Doro, Francesco
2010
46 S1 p. S19-
1 p.
artikel
75 Growth Hormone in Combination with Bisphosphonate Treatment in Osteogenesis Imperfecta Doro, Francesco
2010
46 S1 p. S18-S19
2 p.
artikel
76 Hedgehog signaling in cartilage pathology: a role in osteoarthritis and chondrosarcoma Alman, Benjamin
2010
46 S1 p. S9-
1 p.
artikel
77 HIV treatments and the skeleton: Do NRTIs directly effect bone cells? Taylor, Adam
2010
46 S1 p. S56-
1 p.
artikel
78 HOMOZYGOUS DELETION OF DICKKOPF-1 RESULTS IN A HIGH BONE MASS PHENOTYPE McDonald, Michelle
2010
46 S1 p. S76-S77
2 p.
artikel
79 HORMONE REPLACEMENT THERAPY AND CALCITONIN IN WOMEN WITH BONE MASS LOSS Bazarra-Fernandez, Antonio
2010
46 S1 p. S20-
1 p.
artikel
80 Hormone-stimulated Modulation of Endocytotic Trafficking in Osteoclasts Stenbeck, Gudrun
2010
46 S1 p. S65-
1 p.
artikel
81 How long to treat and what to do when you stop? Ferrari, Serge
2010
46 S1 p. S17-
1 p.
artikel
82 Hypoxia-Inducible Factor (HIF) regulates Osteoclast-Mediated Bone Resorption via Angiopoietin-like 4 (ANGPTL4) Knowles, Helen
2010
46 S1 p. S63-
1 p.
artikel
83 Ibandronate prevents deterioration of bone quality parameters after adjuvant chemotherapy with a taxane Stumpf, Ulla
2010
46 S1 p. S44-
1 p.
artikel
84 IBMS DAVOS 2010: Committee Information 2010
46 S1 p. S1-S2
2 p.
artikel
85 2010 IBMS Davos Workshop: Bone Biology & Therapeutics 2010
46 S1 p. S3-S8
6 p.
artikel
86 IBMS Davos Workshops: Author Index 2010
46 S1 p. S84-S87
4 p.
artikel
87 IBMS Davos Workshops: Keywords Index 2010
46 S1 p. S88-S89
2 p.
artikel
88 Identification and characterization of 2 missense mutations in the LRP4 gene causing increased bone mineral density Piters, Elke
2010
46 S1 p. S55-
1 p.
artikel
89 Identification of Growth Factors Involved in Non-canonical (MCSF Independent) Pathways of Human Osteoclast Formation Taylor, Richard
2010
46 S1 p. S65-
1 p.
artikel
90 Identification of Kaempferol-Regulated Proteins in Rat Calvarial Osteoblasts during Mineralization by Proteomics Trivedi, Ritu
2010
46 S1 p. S57-
1 p.
artikel
91 Identifying epigenetic targets in osteosarcoma and differentiating osteoblasts Baker, Emma
2010
46 S1 p. S44-S45
2 p.
artikel
92 IL-3 inhibits human osteoclast differentiation and bone resorption Gupta, Navita
2010
46 S1 p. S62-
1 p.
artikel
93 Impact of sympathetic neuron signals on bone remodeling and cancer metastasis Elefteriou, Florent
2010
46 S1 p. S11-
1 p.
artikel
94 Improvement of osteoporotic bone quality through minimally invasive laser therapy Ko, Chang-Yong
2010
46 S1 p. S24-S25
2 p.
artikel
95 Increased production of DKK-1 in fibrotic cells and osteoblasts in bone from Paget's disease McCarthy, Helen
2010
46 S1 p. S76-
1 p.
artikel
96 Influence of Different Bisphosphonates on Keratinocytes, HUVEC, Fibroblasts and Osteoblasts in-vitro Walter, Christian
2010
46 S1 p. S58-
1 p.
artikel
97 Influence of high altitude pasture on bone metabolism in goats and sheep Liesegang, Annette
2010
46 S1 p. S74-
1 p.
artikel
98 INFLUENCE OF ZOLENDRONIC ACID INFUSION ON STATE OF CARDIOVASCULAR SYSTEM IN POSTMENOPAUSAL WOMEN Povoroznyuk, Vladyslav
2010
46 S1 p. S29-
1 p.
artikel
99 Inhibition of Osterix Expression and Osteoblast Differentiation by Wnt3a in MC3T3-E1 Cells Thouverey, Cyril
2010
46 S1 p. S57-
1 p.
artikel
100 Initiators and Inhibitors in Vascular Calcification Shanahan, Catherine
2010
46 S1 p. S14-
1 p.
artikel
101 Interleukin-1-beta disrupts normal chondrogenesis and growth plate development Simsa-Maziel, Stav
2010
46 S1 p. S81-
1 p.
artikel
102 Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis Baud'huin, Marc
2010
46 S1 p. S62-S63
2 p.
artikel
103 INTERMITTENT PAMIDRONATE THERAPY FOR TREATMENT OF SEVERE OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN Povoroznyuk, Vladyslav
2010
46 S1 p. S30-
1 p.
artikel
104 INTERMITTENT PAMIDRONATE THERAPY TO TREATMENT CORTICOSTEROID-INDUCED OSTEOPOROSIS Povoroznyuk, Vladyslav
2010
46 S1 p. S29-S30
2 p.
artikel
105 In vitro assessment of osteoblast cell models for bone related research Czekanska, Ewa
2010
46 S1 p. S47-
1 p.
artikel
106 Involvement of the Slit2/Robo1 Pathway in Breast Cancer Bone Metastasis Gonin, Vincent
2010
46 S1 p. S37-
1 p.
artikel
107 Isolation and characterization of osteoclast precursors in vivo Mizoguchi, Toshihide
2010
46 S1 p. S64-
1 p.
artikel
108 Is zoledronate toxic to human periodontal and dental pulp fibroblasts? Agis, Hermann
2010
46 S1 p. S33-S34
2 p.
artikel
109 Lean Body Mass, Not Total Body Size, is a Stronger Determinant of Total Body Bone Mass in Boys Sanchez, Tom
2010
46 S1 p. S80-
1 p.
artikel
110 Lessons Learned from CIC-7 Deficiency: Are All Anti-Resorptives the Same? Karsdal, Morten
2010
46 S1 p. S14-
1 p.
artikel
111 Level of ibandronate in the kidney tissue after long-term application in rats with a normal and a limited renal function Siegrist, B.
2010
46 S1 p. S39-S40
2 p.
artikel
112 Long-term renal safety profile of ibandronate 6 mg infused over 15 minutes Van Moos, Roger
2010
46 S1 p. S37-S38
2 p.
artikel
113 Loss of bone mineralization by the simultaneous ablation of PHOSPHO1 and alkaline phosphatase function Millan, Jose Luis
2010
46 S1 p. S78-
1 p.
artikel
114 MECHANISMS INDUCING LOW BONE DENSITY IN DUCHENNE MUSCULAR DYSTROPHY Rufo, Anna
2010
46 S1 p. S79-S80
2 p.
artikel
115 Mechanisms of Bone Deformation and Fracture Gupta, Himadri
2010
46 S1 p. S12-
1 p.
artikel
116 Mesenchymal cell fraction and differentiation potential in trabecular bone of post-menopausal women Mrak, Emanuela
2010
46 S1 p. S54-S55
2 p.
artikel
117 Mice lacking periostin are resistant to cortical bone loss induced by hind limb suspension Bonnet, Nicolas
2010
46 S1 p. S69-
1 p.
artikel
118 MODELLING BONE HEALING DEFICIENCIES IN NF1 DEFICIENT MICE El-Hoss, Jad
2010
46 S1 p. S52-
1 p.
artikel
119 Modulation of FPPS's activity following NBPs therapy: clinical implications Galluzzo, Sara
2010
46 S1 p. S37-
1 p.
artikel
120 Molecular and functional characterization of group VI calcium-independent phospholipases in osteoblast-like MC3T3-E1 cells Leis, Hans
2010
46 S1 p. S52-
1 p.
artikel
121 Molecular Mechanisms Involved in the Mitogenic Effect of Lactoferrin in Osteoblasts Cornish, Jillian
2010
46 S1 p. S47-
1 p.
artikel
122 MUSCLE CELL CONTRIBUTION TO INTRAMEMBRANOUS BONE HEALING IN A METAPHYSEAL DEFECT MODEL IN MICE Birke, Oliver
2010
46 S1 p. S45-
1 p.
artikel
123 MUSCLE PROGENITORS MAKE A MAJOR CONTRIBUTION TO OPEN FRACTURE REPAIR Liu, Renjing
2010
46 S1 p. S52-S53
2 p.
artikel
124 Nanotherapeutics: Novel engineered nanoparticles promote bone accretion in vivo Beck, George
2010
46 S1 p. S16-
1 p.
artikel
125 Neuropeptide Y is Critical to the Central Effects of the Endogenous Opioid System on Bone Baldock, Paul
2010
46 S1 p. S68-
1 p.
artikel
126 New Experimental Therapeutic Approach by siRNA for Autosomal Dominant Osteopetrosis (ADO) Del Fattore, Andrea
2010
46 S1 p. S61-
1 p.
artikel
127 Noninvasive Assessment of Structural and Mechanical Properties of Trabecular and Cortical Bone by Proton, Deuteron and Phosphorus Magnetic Resonance Wehrli, Felix W.
2010
46 S1 p. S13-S14
2 p.
artikel
128 Nonlinear mechanical response of adherent cells measured by magnetic bead microrheology Kollmannsberger, Philip
2010
46 S1 p. S50-S51
2 p.
artikel
129 Odanacatib in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 3-Year Continued Therapy and Resolution of Effect Reid, Ian
2010
46 S1 p. S31-S32
2 p.
artikel
130 Oleoyl Serine, an Endogenous Regulator of Skeletal Mass Smoum, Reem
2010
46 S1 p. S81-
1 p.
artikel
131 Oncostatin M leads to opposite effects on the proliferation of different primary bone tumors David, Emmanuelle
2010
46 S1 p. S35-S36
2 p.
artikel
132 On the emergence of the spatio-temporal structure of Bone Multicellular Units Buenzli, Pascal
2010
46 S1 p. S70-
1 p.
artikel
133 Osteoblastic Differentiation of Human Mesenchymal Stem Cells Benefits from Low Serum Level and BMP4 Supplementation Cordonnier, Thomas
2010
46 S1 p. S46-S47
2 p.
artikel
134 Osteoclast Formation and Activity on Corning Osteoclast Osteo Assay Surfaces Trikha, Jaishree
2010
46 S1 p. S66-
1 p.
artikel
135 Osteocyte Remodeling of their Perilacunar/canalicular Matrix: Hormonal/Mechanical Regulation Bonewald, Lynda
2010
46 S1 p. S11-
1 p.
artikel
136 Osteogenesis with BMP-2 variant L51P in a critical size defect model in rats Sebald, Hans-Jörg
2010
46 S1 p. S80-S81
2 p.
artikel
137 Osteonecrosis of jaw and pathological fracture in patients with bisphosphonates treatment Vyskocil, Vaclav
2010
46 S1 p. S82-
1 p.
artikel
138 OSTEOPOROSIS AND STDs WITH MENAUPAUSE Bazarra-Fernandez, Antonio
2010
46 S1 p. S34-
1 p.
artikel
139 Osteoporotic Features in an Experimental Rat Model Caused by Liver Cirrhosis Ma, Xing
2010
46 S1 p. S74-S75
2 p.
artikel
140 Ovariectomy-Induced Bone Resorption in the Nonhuman Primate Macaca fascicularis Manton, William
2010
46 S1 p. S75-S76
2 p.
artikel
141 Over-expression of Specific VEGF Isoforms Differentially Enhances and Patterns Bone Formation by Modulating Angiogenesis and Osteoblast Precursors Maes, Christa
2010
46 S1 p. S53-
1 p.
artikel
142 PHASE COMPOSITION OF THE BONE MINERAL AFTER IMPLANTATIONS INTO THE BONE DEFECT BIOLOGICAL HIDROXYAPATITE OK-015 WITH MANGANESE DOPANTS Luzin, Vladyslav
2010
46 S1 p. S40-
1 p.
artikel
143 Post-transcriptional gene silencing using siRNA delivered from Star Nanostructured Polymer Hong, Joanna
2010
46 S1 p. S49-S50
2 p.
artikel
144 Preservation of Cancellous Bone Microarchitecture by an Antagonist of IL-15 in a Mouse Model of Colitis Pierroz, Dominique
2010
46 S1 p. S29-
1 p.
artikel
145 Prevalence of neutralising antibodies to osteoprotegerin in autoimmune disease and severe osteoporosis Riches, Philip
2010
46 S1 p. S79-
1 p.
artikel
146 Proliferative and Osteogenic Differentiation Potentials of Human Fetal Bone Cells Krattinger, Nathalie
2010
46 S1 p. S51-
1 p.
artikel
147 QCT-based Finite Element Analysis Demonstrates Differential Effect of 12 months of treatment with Teriparatide on Vertebral Biomechanics in Postmenopausal Women Treated Previously with Risedronate or Alendronate Borah, Babul
2010
46 S1 p. S46-
1 p.
artikel
148 Quantification of the Order in the Spatial Arrangement of Secondary Osteons in Equine and Canine Long Bones Weinkamer, Richard
2010
46 S1 p. S83-
1 p.
artikel
149 RANKL silencing by siRNA improves therapeutic response of primary osteosarcoma to conventional chemotherapy Rousseau, Julie
2010
46 S1 p. S42-S43
2 p.
artikel
150 Rapid reduction in bone pain following loading-dose ibandronate in patients with recently diagnosed bone metastases Kurth, Andreas A.
2010
46 S1 p. S39-
1 p.
artikel
151 Real time imaging of Gene Expression Ntziachristos, Vasilis
2010
46 S1 p. S10-
1 p.
artikel
152 Receptor activator of NF-kB (RANK) expression associates with bone metastasis in breast carcinomas. Santini, Daniele
2010
46 S1 p. S70-S71
2 p.
artikel
153 Reduced serum serotonin impairs metaphyseal repair in rats Agholme, Fredrik
2010
46 S1 p. S67-
1 p.
artikel
154 REGULATION OF CYSTATHIONINE BETA SYNTHASE BY 1α,25-DIHYDROXYVITAMIN D3 Kriebitzsch, Carsten
2010
46 S1 p. S51-
1 p.
artikel
155 Regulation of semaphorin 3 family members and their receptors by 1α,25-dihydroxyvitamin D3 Verlinden, Lieve
2010
46 S1 p. S66-
1 p.
artikel
156 Re-initiation of risedronate 5 mg daily therapy in patients on long-term treatment after 1 year of discontinuation: effects at 9 and 10 years Eastell, Richard
2010
46 S1 p. S23-S24
2 p.
artikel
157 Relationship of uncarboxylated osteocalcin concentrations and ucOC/cOC index with the glycemic status in type 2 diabetes mellitus Bernal, Jose Rafael Villafan
2010
46 S1 p. S56-
1 p.
artikel
158 Relative uptake of risedronate in trabecular and cortical bone Ebetino, Frank
2010
46 S1 p. S70-
1 p.
artikel
159 Renal safety of ibandronate in the treatment of myeloma patients Bergner, Raoul
2010
46 S1 p. S35-
1 p.
artikel
160 Results From a Phase 3 Randomized, Double-Blind, Double-Dummy Clinical Trial Comparing Denosumab with Zoledronic Acid for the Management of Bone Metastases in Patients with Advanced Solid Tumors or Multiple Myeloma von Moos, Roger
2010
46 S1 p. S44-
1 p.
artikel
161 Results of a prospective, randomized, double-blind, double-dummy, Phase 3 study comparing denosumab with zoledronic acid for the treatment of breast cancer patients with bone metastases Body, Jean-Jacques
2010
46 S1 p. S36-S37
2 p.
artikel
162 Risedronate Reduces Intracortical Porosity in Postmenopausal Women with Osteoporosis as Measured by a New 3D Micro-CT Method Borah, Babul
2010
46 S1 p. S61-
1 p.
artikel
163 RISEDRONIC ACID AND RALOXIFENE IN POST-MENOPAUSAL WOMEN WITH OSTEOPOROSIS Bazarra-Fernandez, Antonio
2010
46 S1 p. S20-
1 p.
artikel
164 Role of the Na-dependent phosphate transporters, PiT-1 and PiT-2, in the osteoblastic response to phosphate in vitro and in bone growth in vivo Bourgine, Annabelle
2010
46 S1 p. S46-
1 p.
artikel
165 Safety and Tolerability of Bazedoxifene in Postmenopausal Women With Osteoporosis: Results of a 5-year, Randomized, Placebo-controlled Phase 3 Trial de Villiers, T.
2010
46 S1 p. S21-
1 p.
artikel
166 Sclerostin is an Important Target for Stimulating Bone Formation, Restoring Bone Mass and Enhancing Fracture Healing Ke, David
2010
46 S1 p. S15-
1 p.
artikel
167 SCLEROSTIN NEUTRALISING ANTIBODY ENHANCES HEALING OF TIBIAL METAPHYSEAL DEFECT IN AN OVX RAT MODEL McDonald, Michelle
2010
46 S1 p. S25-
1 p.
artikel
168 SCLEROSTIN NEUTRALIZING ANTIBODY ENHANCES BONE HEALING DURING DISTRACTION OSTEOGENESIS IN RATS McDonald, Michelle
2010
46 S1 p. S27-
1 p.
artikel
169 Sclerostin regulation and mode of action Kneissel, Michaela
2010
46 S1 p. S11-
1 p.
artikel
170 Significantly Reduced Burst Release by Sequestration of Protein Delivery Vehicle Within Unique Three-Phase Composite Scaffold for Bone Tissue Engineering and Regenerative Medicine Grant, David
2010
46 S1 p. S24-
1 p.
artikel
171 Skeletal status assessed by quantitative ultrasound in children with bronchial asthma Adamczyk, Piotr
2010
46 S1 p. S66-S67
2 p.
artikel
172 SOCS2 Regulates Growth by Inhibiting GH Signalling in Chondrocytes Pass, Chloe
2010
46 S1 p. S78-S79
2 p.
artikel
173 Sox2 Is Required For The Self-renewal Of The Osteoblast Lineage Mansukhani, Alka
2010
46 S1 p. S53-
1 p.
artikel
174 Spleen tyrosine kinase (Syk) suppressively regulates the osteoblastic differentiation through p44/42MAPK and PKC Yoshida, Kiyoshi
2010
46 S1 p. S59-
1 p.
artikel
175 Sustained Efficacy of Bazedoxifene in Preventing Fractures in Postmenopausal Women With Osteoporosis: Results of a 5-year, Randomized, Placebo-controlled Study Silverman, S.
2010
46 S1 p. S32-
1 p.
artikel
176 Synergistic effect of Apomine and Lovastatin on osteosarcoma cell growth in vitro and in vivo Moriceau, Gatien
2010
46 S1 p. S38-
1 p.
artikel
177 T Cells Involvement in PTH Anabolic Actions Pacifici, Roberto
2010
46 S1 p. S12-
1 p.
artikel
178 The Ability of Bisphosphonates and Their Analogues to Penetrate the Osteocyte Network is Dependent on Affinity for Bone Coxon, Fraser
2010
46 S1 p. S22-
1 p.
artikel
179 The Adverse Effects and Safety of Bisphosphonates Cummings, Steve
2010
46 S1 p. S16-
1 p.
artikel
180 The Corning Osteo Assay Surface for Drug Discovery. A. Fawad Faruqi, and James Beltzer Faruqi, Fawad
2010
46 S1 p. S61-S62
2 p.
artikel
181 The Corning Osteo Assay Surface for the Study of Bone Metastatic Cancer Rao, Hanna
2010
46 S1 p. S34-
1 p.
artikel
182 The differential effects of hypoxia on the osteo-chondrogenic potential of human adipose-derived stem cells Merceron, Christophe
2010
46 S1 p. S77-
1 p.
artikel
183 The differentiation and calcification of vascular smooth muscle cells is associated with an osteocyte phenotype Zhu, Dongxing
2010
46 S1 p. S75-
1 p.
artikel
184 The effect of cobalt and chromium ions at clinically relevant concentrations on human osteoblast and osteoclast physiology in vitro: implications for skeletal health Andrews, Rebecca
2010
46 S1 p. S71-
1 p.
artikel
185 The Effect of Denosumab on Bone Turnover Markers (BTM) in Postmenopausal Women With Osteoporosis Cummings, Steven
2010
46 S1 p. S28-
1 p.
artikel
186 The N-terminal domain of the bone protein PRoline/arginine-rich End Leucine-rich repeat Protein (PRELP) impairs osteoclast formation by a new mechanism inhibiting NF-kappaB signaling Rucci, Nadia
2010
46 S1 p. S64-S65
2 p.
artikel
187 The Pathophysiology and Treatment of Glucocorticoid Induced Osteoporosis Lane, Nancy
2010
46 S1 p. S15-
1 p.
artikel
188 The prevention of bone mineral density loss in glucocorticoid-treated inflammatory bowel disease patients Cokolic, Miro
2010
46 S1 p. S21-S22
2 p.
artikel
189 Therapeutic Targeting to Bone: Enzyme Replacement Treatment for Hypophosphatasia Whyte, Michael
2010
46 S1 p. S13-
1 p.
artikel
190 The role of calcium-phosphate crystals in the phosphate-dependent activation of osteoblasts Khoshniat, Solmaz
2010
46 S1 p. S50-
1 p.
artikel
191 The role of disseminated tumour cells and circulating tumour cells in the early development of (bone) metastasis Pantel, Klaus
2010
46 S1 p. S18-
1 p.
artikel
192 Toxicity of Bisphosphonate-treated Bones to Epithelial Cells is Related to Bisphosphonate Potency - Mechanism of ONJ? Reid, Ian
2010
46 S1 p. S42-
1 p.
artikel
193 Trapidil abolishes the increase in bone formation induced by ovariectomy in rats Kumar, Hashe
2010
46 S1 p. S51-S52
2 p.
artikel
194 Treatment-Naive Osteoporosis Patients Strongly Prefer Once-Yearly Intravenous Therapy: A Time Trade-Off Study Wark, John
2010
46 S1 p. S33-
1 p.
artikel
195 TREATMENT OF CONGENITAL PSEUDARTHROSIS OF THE TIBIA USING RECOMBINANT BONE MORPHOGENETIC PROTEIN AND BISPHOSPHONATES Birke, Oliver
2010
46 S1 p. S20-S21
2 p.
artikel
196 Treatment of patients with changed bone metabolism under bisphosphonate medication - outcome of the Chemnitz long-term study Linek, Wigbert
2010
46 S1 p. S73-
1 p.
artikel
197 Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg Wark, John
2010
46 S1 p. S33-
1 p.
artikel
198 Urocortin prevents bone resorption by inhibiting a constitutively active transient receptor potential-like cation channel Combs, Charlotte
2010
46 S1 p. S59-
1 p.
artikel
199 Vascular Calcification - The Role of BGP in Chondrogenic-like Differentiation of Vascular Smooth Muscle Cells Idelevich, Anna
2010
46 S1 p. S72-
1 p.
artikel
200 Vertical bone formation on the CaP implant surface Palarie, Victor
2010
46 S1 p. S55-
1 p.
artikel
201 Vitamin D is a multifunctional hormone Bouillon, Roger
2010
46 S1 p. S17-
1 p.
artikel
202 Whole bone testing in small animals: Why do our results not reach statistical significance? Impact and reduction of systematic failure Prodinger, Peter
2010
46 S1 p. S31-
1 p.
artikel
203 Zoledronate-Induced IPP/ApppI (Phosphoantigen) Accumulation in Human Breast Cancer Cells Correlates with Vγ9VΔ2 T Cell-Mediated Cancer Cell Death In Vitro and In Vivo Benzaid, Ismahene
2010
46 S1 p. S43-
1 p.
artikel
204 Zoledronic acid as new adjuvant therapeutic agent for Ewing's sarcoma Odri, Guillaume
2010
46 S1 p. S42-
1 p.
artikel
205 Zoledronic acid induces IPP release from cancer cells which causes Vgamma9Vdelta2 T cell expansion in PBMCs Arkko, Satu
2010
46 S1 p. S40-S41
2 p.
artikel
                             205 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland